MONTREAL, Aug. 17, 2017 /CNW Telbec/ - Pendopharm, the makers of the #1 doctor-recommended laxative in its class Lax-A-Day (PEG 3350), introduces 4 products to the Lax-A family in order to offer a tailored approach to treating occasional constipation, because different needs call for different laxatives :
The different causes of constipation
Nearly a quarter of Canadians are affected by constipation every year. Constipation can occur when the colon absorbs too much water or when its muscle contractions slow down. Many lifestyle factors can contribute to this, including: travel, a lack of fibre in one's diet, certain medications, pregnancy, or stress. Each of these causes can call for a different solution to relieve one's symptoms.
Lax-A-Day: the #1 doctor-recommended PEG 3350*
Clinically proven, Lax-A-Day, the #1 doctor-recommended laxative in its class, provides gentle and effective relief for people suffering from occasional constipation. Available in a convenient packaging of 60 doses/1020g with an easy grip, Lax-A-Day increases the frequency of bowel movements without generating a sudden urgency to go. Sold at a very competitive cost per dose, Lax-A-Day also offers a grit-free, 100% soluble and taste free oral solution that is well tolerated by both men and women.
For more information, please visit: www.laxasolutions.com
These products may not be right for everyone. Always read and follow the label.
*IMS Compuscript PEG3350 – Rx units - past 24 months – April 2017.
LAX-A-DAY® (Polyethylene Glycol 3350 Powder for Oral Solution) is indicated as a laxative for the treatment of occasional constipation.
Lax-A Nema, Lax-A Nema Pediatric are indicated for relief of occasional constipation. Lax-A Senna is indicated for comfortable relief of occasional constipation. Lax-A Fibre is indicated to provide gentle relief of constipation and/or irregularity.
About Pendopharm
PENDOPHARM was established in 2010 as the specialty branded division of Pharmascience Inc., a Canadian privately-owned company and the largest pharmaceutical employer in Quebec.. PENDOPHARM is focused on growing its gastroenterology portfolio with innovative products for the global market. In addition to Gastroenterology, the PENDOPHARM pipeline spans multiple therapeutic areas including Allergy, Cough & Cold, Orthopedics and Specialty Products. Strategically committed to growth, PENDOPHARM is actively engaged in licensing, partnering, developing, and marketing specialty prescription medicines as well as consumer brands. For more information, please visit www.pendopharm.com.
SOURCE Pendopharm
Polina Lichagina, BICOM Communications, [email protected], 514-223-6770
Also from this source
Share this article